Search This Blog

Monday, April 20, 2026

AnaptysBio completes First Tracks spin-off, relaunches as royalty-focused virtual company

 

AnaptysBio completes First Tracks spin-off, relaunches as royalty-focused virtual company with $140–$145 million net cash

  • Royalty-focused virtual company will exclusively manage GSK and Vanda collaborations following First Tracks Biotherapeutics spin-off.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)